Patents by Inventor Santanu Bose

Santanu Bose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating inflammation associated airway diseases and viral infections
    Patent number: 12084493
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: September 10, 2024
    Assignee: Washington State University
    Inventors: Santanu Bose, Philippe Tessier
  • Methods Of Treating Inflammation Associated Airway Diseases And Viral Infections
    Publication number: 20210032323
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Application
    Filed: August 17, 2020
    Publication date: February 4, 2021
    Inventors: Santanu BOSE, Philippe TESSIER
  • Methods of treating inflammation associated airway diseases and viral infections
    Patent number: 10745474
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: August 18, 2020
    Assignees: Washington State University, The Board of Regents of the University of Texas Systems
    Inventors: Santanu Bose, Philippe Tessier
  • Methods Of Treating Inflammation Associated Airway Diseases And Viral Infections
    Publication number: 20180258162
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Application
    Filed: May 22, 2018
    Publication date: September 13, 2018
    Inventors: Santanu Bose, Philippe Tessier
  • Methods of treating inflammation associated airway diseases and viral infections
    Patent number: 10005833
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: June 26, 2018
    Assignees: WASHINGTON STATE UNIVERSITY, THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Santanu Bose, Philippe Tessier
  • Methods Of Treating Inflammation Associated Airway Diseases And Viral Infections
    Publication number: 20160194387
    Abstract: The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.
    Type: Application
    Filed: December 31, 2015
    Publication date: July 7, 2016
    Inventors: Santanu Bose, Philippe Tessier
  • Methods and compositions for treatment of cancer using oncolytic RSV activity
    Patent number: 9241998
    Abstract: The present invention relates generally to methods and compositions employing the oncolytic activity of respiratory syncytial virus (RSV) to treat cancer and other neoplastic disorders.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: January 26, 2016
    Assignee: Board of Regents, The University of Texas System
    Inventors: Santanu Bose, Bandana Chatterjee
  • METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER USING ONCOLYTIC RSV ACTIVITY
    Publication number: 20100303839
    Abstract: The present invention relates generally to methods and compositions employing the oncolytic activity of respiratory syncytial virus (RSV) to treat cancer and other neoplastic disorders.
    Type: Application
    Filed: May 21, 2008
    Publication date: December 2, 2010
    Inventors: Santanu Bose, Bandana Chatterjee
  • Transcobalamin mediated transport of vitamins B12 in intrinsic factor or receptor deficient patient
    Patent number: 6183723
    Abstract: A method for oral treatment of patients using different types of drugs that are not usually transported to circulation, if administered orally, is disclosed. Because the TC II-Cbl complex is stable to acid and proteolytic enzymes both outside and inside the intestinal absorptive cells, the method consists of oral administration of a drug bound to TC II-Cbl complex. In addition, the method can also be used for delivering Cbl to a large number of patients who do not absorb Cbl due to a variety of causes such as surgery of their stomach (ulcers) or of their terminal ileum (Crohn's disease).
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: February 6, 2001
    Assignee: MCW Research Foundation
    Inventors: Bellur Seetharam, Santanu Bose